Sucralose CAS 56038-13-2: The World’s Most Versatile High-Intensity Sweetener, Engineered for Tomorrow’s Formulations
Sucralose CAS 56038-13-2 (1,6-dichloro-1,6-dideoxy-β-D-fructofuranosyl-4-chloro-4-deoxy-α-D-galactopyranoside) is the most commercially successful high-intensity sweetener globally, delivering approximately 600 times the sweetness of sucrose with zero caloric contribution. Our sucralose meets FCC, USP, and JECFA specifications with purity ≥98.0% (HPLC), delivering the clean sweetness profile and exceptional stability that food and beverage formulators demand across pH 2–8 and temperatures up to 250°C in baking applications.
Technical Highlights & Quality Assurance
1. Multi-Stage Purification Protocol: Our sucralose undergoes sequential recrystallization and activated carbon treatment, achieving assay 98.0–102.0% with hydrolytic byproducts (4-chloro-4-deoxy-galactose, 1,6-dichloro-fructose) individually maintained <0.1%—below organoleptic detection threshold and well within JECFA ADI safety margins.
2. Crystal Morphology Control: Through controlled cooling crystallization, we produce uniform white crystalline powder with D50 80–150 μm and bulk density 0.65–0.75 g/mL. The consistent crystal habit ensures rapid dissolution (<45 seconds at 25°C in water at 10% w/v concentration) without clumping or dusting during automated batching operations.
3. Stability Under Process Conditions: Our sucralose demonstrates <1% degradation after 24 hours at pH 3.0 and 95°C—the standard UHT processing condition for dairy and juice beverages. No detectable hydrolysis products form at baking temperatures up to 220°C for 30 minutes in cookie matrices, confirming suitability for the full range of baked good applications.
4. Trace Organochlorine Control: Residual chlorinated solvent levels (dichloromethane, chloroform) maintained <10 ppm each via headspace GC-MS, fully compliant with EU Regulation 231/2012 and FDA 21 CFR 172.831 food additive specifications.
Competitive Comparison
| Parameter | Our Sucralose | Chinese Competitor C | Indian Manufacturer | UK Supplier (Tate & Lyle) |
|---|
| Assay (HPLC) | 98.0–102.0% | 98.0–102.0% | 97.5–102.0% | 98.0–102.0% |
| Hydrolysis Products | <0.1% each | <0.2% each | <0.3% each | <0.1% each |
| Residual Solvents | <10 ppm | <20 ppm | <50 ppm | <10 ppm |
| Bulk Density | 0.65–0.75 g/mL | 0.50–0.70 g/mL | 0.55–0.70 g/mL | 0.65–0.75 g/mL |
| pH Stability | 2–8 (no loss) | 3–7 (no loss) | 3–7 (no loss) | 2–8 (no loss) |
| Price ($/kg FCL) | $25–35 | $22–30 | $20–28 | $45–60 |
| Certifications | FCC, USP, Halal, Kosher | FCC, Halal | FCC | FCC, USP, CEP |
Target Customer Scenarios
Carbonated Soft Drink Manufacturer — Latin America
A major LATAM CSD producer reformulated their flagship cola with our sucralose in a sucrose/sucralose blend, achieving 35% sugar reduction while maintaining Brix-matched sweetness intensity in triangle testing (p=0.34, no significant difference detected by trained panel, n=48). The reformulation saved an estimated $4.7M annually in sugar costs and qualified the product for front-of-pack sugar reduction claims under new regional labeling regulations.
Pharmaceutical OTC Manufacturer — Europe
An EU OTC drug manufacturer adopted our sucralose for a pediatric antibiotic suspension. Taste-masking evaluation (electronic tongue + pediatric patient panel n=60) confirmed complete bitterness suppression of amoxicillin/clavulanic acid at 0.08% sucralose loading. The product received PMDA and EMA approval without reformulation across 18-month stability. “The absence of aftertaste at low concentrations was key for pediatric compliance.” — Formulation Lead.
Protein Bar Brand — North America
A premium protein bar brand replaced acesulfame-K and maltitol syrup with our sucralose plus soluble corn fiber, achieving 1g sugar per bar with 20g protein. The product maintained soft texture over 12 months (hardness <5N via texture analyzer) and won “Best Low-Sugar Protein Bar” in a leading consumer publication within 4 months of launch. First-year retail sales exceeded $12M across 8,500+ doors.
Industry Trends
- Sugar Reduction Mandates: Over 60 countries have now implemented sugar taxes or front-of-pack labeling mandates, driving sucralose demand at 4.8% CAGR. Blended sweetener systems utilizing sucralose as the high-intensity component are the dominant formulation strategy.
- Clean Taste Profile Demand: Consumer rejection of steviol glycoside bitterness is redirecting formulators toward sucralose-stevia blends or pure sucralose systems, particularly in dairy and RTD tea categories where off-notes are most detectable.
- Pharmaceutical Expansion: Sucralose use as a pharmaceutical excipient is growing at 7.2% CAGR, driven by pediatric and geriatric oral dosage forms where palatability directly impacts adherence and therapeutic outcomes.
Your message must be between 20-3,000 characters!
